tiprankstipranks
Perspective Therapeutics, Inc. (CATX)
XASE:CATX
US Market
CATX
Perspective Therapeutics
RESEARCH TOOLSreports
Want to see CATX full AI Analyst Report?

Perspective Therapeutics (CATX) Stock News & Sentiment

1,634 Followers
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
4d ago
DE
HD
CATX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CATX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5d ago
CATX
Perspective Therapeutics Highlights Q1 Progress and Strengthened Finances
Premium
Company Announcements
Perspective Therapeutics Highlights Q1 Progress and Strengthened Finances
11d ago
8K
CATX
Perspective Therapeutics Highlights Alpha-Targeted Oncology Strategy Update
Premium
Company Announcements
Perspective Therapeutics Highlights Alpha-Targeted Oncology Strategy Update
17d ago
8K
CATX
Perspective Therapeutics Highlights Encouraging Interim Neuroendocrine Tumor Data
Premium
Company Announcements
Perspective Therapeutics Highlights Encouraging Interim Neuroendocrine Tumor Data
1M ago
8K
CATX
Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline
Premium
Company Announcements
Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline
2M ago
8K
CATX
Reiterating Buy on Perspective Therapeutics: Strong Cash Runway, Improving Earnings Outlook, and Clinical Milestones Support $13 DCF Valuation
Premium
Ratings
Reiterating Buy on Perspective Therapeutics: Strong Cash Runway, Improving Earnings Outlook, and Clinical Milestones Support $13 DCF Valuation
2M ago
CATX
More CATX News >

CATX News on the Web

CATX Initiates Key Patient Cohorts in Neuroendocrine and Solid Tumor Trials—Front-Loaded Dosing Strategy Under Evaluation
Market Chameleon
Neutral
Options Volatility and Implied Earnings Moves This Week, May 18 – May 22, 2026
TipRanks News
Neutral
Perspective Therapeutics doses first patients in two Phase 1/2a studies
TipRanks News
Bullish
CATX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TipRanks News
Neutral
LifeSci Capital Remains a Buy on Perspective Therapeutics (CATX)
TipRanks News
Neutral
Perspective Therapeutics price target lowered to $6 from $7 at BofA
TipRanks News
Neutral
Analysts Are Bullish on These Healthcare Stocks: SI-Bone (SIBN), Perspective Therapeutics (CATX)
TipRanks News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alector (ALEC), Spyre Therapeutics (SYRE) and Perspective Therapeutics (CATX)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
CATX
Sector Average
Media Buzz
This Week5 articles
Weekly Average7 articles
News Sentiment
This Week100%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CATX’s Media Buzz Sentiment?
5 articles about CATX were published this week. In an average week, 7 articles are published.
    What is CATX’s weekly average amount of articles?
    In an average week, 7 articles about CATX are published.
      What is CATX’s News Sentiment?
      100% of articles about CATX were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        IMVTImmunovant
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        Showing the stocks with the most bullish news sentiment over the past week